Cold weather significantly increases the risk of heart attacks and strokes. The body's natural responses to cold, like ...

Wendy Clark, from Sudbury, Suffolk, had been smoking for 43 years before she had a heart attack in September. She was warned ...

Formoterol is a LABA which works as rapidly as salbutamol and is as effective in treating acute symptoms. In a combination ...

Qnovia announced that it raised $16 million in Series B funding to support its inhaled smoking cessation therapy platform.

The funding will primarily be allocated toward the submission of an application to British regulators to allow for the ...

Aerosol delivery devices are hand-held, portable drug delivery devices. They consist of suspension of solid or liquid particles in a carrier gas, which makes feasible for treatment of respiratory and ...

Qnovia, a Richmond startup focused on smoking-cessation technology, has raised $16 million in a Series B round.

Qnovia, Inc., a pharmaceutical company who recently announced the clearance of its Investigational New Drug (IND) application by the U.S. Food and Drug Administration (FDA) for the RespiRxtm Nicotine ...

Qnovia, Inc., a pharmaceutical company who recently announced the clearance of its Investigational New Drug (IND) application by the U.S. Food and Drug Administration (FDA) for the RespiRx™ Nicotine ...

IT’S that time of year where we’re greeted by a cacophony of coughs, sneezes and sniffles wherever we go. You might think a ...

Patients with COPD had slightly more major adverse cardiovascular events after initiating single-inhaler triple therapy vs a LABA-ICS inhaler.

Are you looking to quit smoking? Taking the very first step towards a smoke-free future is often the most difficult.